Galectin Therapeutics (GALT) Tops Q2 EPS by 4c

August 9, 2016 7:52 AM EDT
Get Alerts GALT Hot Sheet
Trade GALT Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Galectin Therapeutics (NASDAQ: GALT) reported Q2 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment